Oxygen free radicals and the penis

Bibliography

• AYTAC IA, MCKINLAY JB, KRANE RJ: The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BIU Int. (1999) 84:50–56.
   Google Scholar
• ANDERSSON KE, WAGNER G: Physiology of penile erection. Physiol Rev (1995) 75(1):191–236.
   PubMed Web of Science ®Google Scholar
• •Comprehensive and detailed review of erectile physiology.
   Google Scholar
• LUE TF: Erectile dysfunction. N Engl. Med. (2000) 342(24):1802–1813.
   PubMed Web of Science ®Google Scholar
• MELMAN A, GINGELL JC: The epid-emiology and pathophysiology of erectile dysfunction. Urol. (1999) 161:5–11.
   Google Scholar
• RAJFER J, ARONSON WJ, BUSH PA, DOREY FJ, IGNARRO LJ: Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl. Med. (1992) 326(2):90–94.
   PubMed Web of Science ®Google Scholar
• BURNETT AL: Nitric oxide in the penis: physiology and pathology. Urol. (1997) 157:320–324.
   Google Scholar
• BECKMAN JS, KOPPENOL WH: Nitric oxide, superoxide and peroxynitrite: the good the bad and the ugly. Am. j Physiol (1996) 40:C1424–C1437.
   Google Scholar
• IGNARRO LJ, CIRINO G, CASINI A, NAPOLI C: Nitric oxide as a signalling molecule in the vascular system: an overview. Cardiovasc. Pharmacol (1999) 34:879–886.
   PubMed Web of Science ®Google Scholar
• ••Up to date, definitive account of integratedNO biochemistry.
   Google Scholar
• ZALBA G, BEAUMONT J, SAN JOSE G, FORTUNO A, FORTUNO MA, DIEZ J: Vascular oxidant stress: molecular mechanisms and pathophysiological implications. Physiol Biochem. (2000) 56(1):57–64.
   Google Scholar
• JEREMY JY, ANGELINI GD, KHAN M et al.: Platelets, oxidant stress and erectile dysfunction: an hypothesis. Cardiovasc. Res. (2000) 46(1):50–54.
   PubMedGoogle Scholar
• ••An outline of the potential role ofendothelial cell dysfunction and associated neutrophil- and platelet-mediated vasculopathy, in ED pathogenesis.
   Google Scholar
• YOUNG IS, WOODSIDE JV: Antioxidants in health and disease. j Clin. Pathol (2001) 54:176–186.
   PubMed Web of Science ®Google Scholar
• •Excellent review of cellular antioxidant defence and classification of therapeutic antioxidants.
   Google Scholar
• DARLEY-USMAR V, WHITE R: Disruption of vascular signalling by the reaction of nitric oxide with superoxide: implications for cardiovascular disease. Exp. Physiol (1997) 82:305–316.
   PubMedGoogle Scholar
• LAIGHT DW, CARRIER MJ, ANGGARD EE: Antioxidants, diabetes and endothelial dysfunction. Cardiovasc. Res. (2000) 47:457–464.
   PubMed Web of Science ®Google Scholar
• KOJDA G, HARRISON D: Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res. (1999) 43:562–571.
   PubMed Web of Science ®Google Scholar
• •A recent review of the pathophysiological role of ROS in vascular disease.
   Google Scholar
• STROES ES, VAN FAASSEN EE, VAN LONDEN GJ, RABELINK TJ: Oxygen radical stress in vascular disease: the role of endothelial nitric oxide synthase. Cardiovasc. Pharmacol (1998) 32\(Suppl. 3):514–521.
   Google Scholar
• WARNHOLTZ A et al.: Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis. Circulation (1999) 99:2027–2033.
   PubMed Web of Science ®Google Scholar
• HINK U, LI H, MOLLNAU H et al.: Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. (2001) 88(2):E14–22.
   PubMed Web of Science ®Google Scholar
• GRYGLEWSKI RJ, PALMER RI\4J, MONCADA S: Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature (1986) 320:454–456.
   PubMed Web of Science ®Google Scholar
• •First report of the inactivation of NO by superoxide anions.
   Google Scholar
• WIZTUM JL: The oxidation hypothesis ofatherosclerosis. Lancet (1994) 344:793–795.
   PubMedGoogle Scholar
• TOMAIAN DJFK JR, VITA JA: Antioxidants and the bioactivity of endothelium-derived nitric oxide. Cardiovasc. Res. (2000) 47:426–435.
   PubMedGoogle Scholar
• KHAN MA, THOMPSON CS, MUMTAZ FH et al.: The effect of nitric oxide and peroxynitrite on rabbit cavernosal smooth muscle. Worldj Urol. (2001) 19(3):220–224.
   PubMedGoogle Scholar
• KATUSIC ZS, VANHOUTTE PM: Superoxide anion is an endothelium-derived contracting factor. Am." Physiol (1989) 257:H33–H37.
   Google Scholar
• O'HARA Y, PETERSON TE, HARRISON DG: Hypercholesterolaemia increases endothelial superoxide anion production. " Clin. Invest. (1993) 91:2546–2551.
   PubMedGoogle Scholar
• HONING MLH et al.: Nitric oxide availability in diabetes mellitus. Diabet. Metab. Rey (1998) 14:214–249.
   Google Scholar
• MCINTYRE M, BOHR DF, DOMINICZAK AF: Endothelial function in hypertension: the role of the superoxide anion. Hypertension (1999) 34:539–545.
   PubMed Web of Science ®Google Scholar
• JEREMY JY, MIKHAILIDIS DP: Cigarette smoking and erectile dysfunction. Royal Soc. Health (1998) 118(3):151–155.
   PubMedGoogle Scholar
• FELDMAN HA, GOLDSTEIN I, HATZICHRISTOU DG, KRANE RJ, MCKINLAY JB: Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study. Urol. (1994) 151:54–62
   Google Scholar
• •Definitive epidemiological study demonstrating the link between cardiovascular risk factors and ED in the general population.
   Google Scholar
• MARTIN-MORALES A, SANCHEZ-CRUZ JJ, SAENZ DE TEJADA I, RODRIGUEZ-VELA L, JIMENEZ-CRUZ JF, BURGOS-RODRIGUEZ R: Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologica De La Disfuncion Erectil
   Google Scholar
• •• Masculina study. J. UM] (2001) 166:569–575.
   Google Scholar
• MANNINO DM, KLEVENS RM, FLANDERS WD: Cigarette smoking: an independent risk factor for impotence. Am. J. Epidemiol (1994) 140(11):1003–1008.
   PubMed Web of Science ®Google Scholar
• BURCHARDT M, BURCHARDT T, BAER L et al.: Hypertension is associated with severe erectile dysfunction. J. Um]. (2000) 164(4):1188–1191.
   Google Scholar
• SCHIAVI RC, STIMMEL BB, MANDELI J, RAYFIELD EJ et al.: Diabetes mellitus and male sexual function: a controlled study. Diabetologia (1993) 36:745–751.
   PubMed Web of Science ®Google Scholar
• WET M: Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. Am. J. Epidemiol (1994) 140:930–937.
   PubMedGoogle Scholar
• GREENSTEIN A, CHEN J, MILLER H, MATZKIN H, VILLA Y, BRAF Z: Does severity of ischaemic coronary disease correlate with erectile function? Int. J. Impot. Res. (1997) 9(3):123–126.
   PubMedGoogle Scholar
• •Demonstration of the relationship between ED and coronary artery disease severity, consolidating the concept of a shared aetiology.
   Google Scholar
• PRITZKER M: The penile stress test: a window to the hearts of man? Circulation (1999) 100\(Suppl. 1):711.
   Google Scholar
• BURCHARDT M, BURCHARDT T, ANASTASIADIS AG et al.: Erectile dysfunction is a marker for cardiovascular complications and psychological functioning in men with hypertension. mt. .1 Impot. Res. (2001) 13:276–281.
   Google Scholar
• SULLIVAN ME, THOMPSON CS, DASHWOOD MR et al: Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease? Cardiovasc. Res. (1999) 43:658–665.
   Google Scholar
• DE ANGELIS L, MARFELLA MA, SINISCALCHI M et al.: Erectile and endothelial dysfunction in Type II diabetes: a possible link. Diabetologia (2001) 44:1155–1160.
   PubMed Web of Science ®Google Scholar
• FRANCAVILLA S et at Erectile dysfunction is associated with endothelial cell activation also in absence of vascular risk factors. Int. J. Impot. Res. (2001) 13 (Suppl. 4):537.
   Google Scholar
• CARTLEDGE IJ, EARDLEY I, MORRISON JFB: Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin. BJU Int. (2000) 85:735–741.
   PubMedGoogle Scholar
• MARTIN W, MCALLISTER KHM, PAISLEY K: NANC neurotransmission in the bovine retractor penis muscle is blocked by superoxide anion following inhibition of superoxide dismutase with diethyld-thiocarbamate. Neuropharmacology (1994) 33(11):1293–1301.
   PubMedGoogle Scholar
• PAISLEY K, MARTIN W: Blockade of nitrergic transmission by hydroquinone, hydroxycobalamin and carboxy-PTIO in bovine retractor penis: role of superoxide anion. Br J Pharmacol (1996) 117:1633–1638.
   PubMedGoogle Scholar
• BOUSHEY CJ, BERESFORD SA, OMENN GS, MOTULSKY AG: A quantative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA (1995) 274:1049–1057.
   PubMed Web of Science ®Google Scholar
• EMSLEY AM, JEREMY JY, GOMES GN,ANGELINI GD, PLANE F: Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta. Br. J Pharmacol (1999) 26(4):1034–1040.
   Google Scholar
• KHAN MA, THOMPSON CS, EMSLEY AM et al.: The interaction of homocysteine and copper markedly inhibits the relaxation of rabbit corpus cavernosum: new risk factors for angiopathic erectile dysfunction? BJU Int. (1999) 84:720–724.
   Google Scholar
• •First demonstration that homocysteine impairs cavernosal endothelial-dependent relaxation through superoxide formation.
   Google Scholar
• AZADZOI K, SAENZ DE, TEJADA I: Hypercholesterolaemia impairs endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Um]. (1991) 146:238–240.
   Google Scholar
• KIM JH, KLYACHKIN ML, SVENDSEN E, DAVIES MG, HAGEN PO, CARSON CC 3RD: Experimental hypercholesterol-aemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. J Um]. (1994) 151:198–205.
   Google Scholar
• KIM SC, KIM IK, SEO KK, BAEK KJ, LEE MY: Involvement of superoxide radical in the impaired endothelium-dependant relaxation of cavernous smooth muscle in hypercholesterolaemic rabbits. Um]. Res. (1997) 25:341–346.
   Google Scholar
• ••Demonstration of increased superoxideformation, increased SOD activity, and decreased endothelium-dependent relaxation in the cavernosum of hypercholesterolaemic rabbits.
   Google Scholar
• ROSENFIELD M: Oxidised LDL affects multiple atherogenic cellular responses. Circulation (1991) 83:2137–2140.
   PubMedGoogle Scholar
• JESSUP W: Oxidised lipoproteins and nitric oxide. Carr. Opin. Lipidol (1996) 7:274–280.
   PubMedGoogle Scholar
• AHN T, AZADZOI K, SAENZ DE, TEJADA I: Oxidised low density lipoproteins elicit contraction of rabbit corpus cavernosum smooth muscle. J Um]. (1992) 147:455A.
   Google Scholar
• AHN TY, GOMEZ-CORONADO D, MARTINEZ V, CUEVAS P, GOLDSTEIN I, SAENZ DE TEJADA I: Enhanced contractility of rabbit corpus cavernosum smooth muscle by oxidised low-density lipoproteins. Int. J Impot. Res. (1999) 11(1):9–14.
   PubMedGoogle Scholar
• AZADZOI K, TEJADA ISD: Diabetes mellitus impairs neurogenic and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J Um]. (1992) 148:1587–1591.
   Google Scholar
• CARTLEDGE JJ, EARDLEY I, MORRISON JFB: Nitric oxide-mediated corpus cavernosal smooth muscle relaxation is impaired in ageing and diabetes. BJU Int. (2001) 87:394–401.
   PubMed Web of Science ®Google Scholar
• SAENZ DE, TEJADA I: Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence. N Engl. J. Med. (1989) 320(16):1025–1030.
   PubMedGoogle Scholar
• GUR S, OZTURK B, KARAHAN ST: Impaired endothelium-dependent and neurogenic relaxation of corpus cavernosum from diabetic rats: improvement with L-arginine. Um]. Res. (2000) 28(1):14–19.
   Google Scholar
• YILDIRIM S, AYAN S, SARIOGLU Y, GULTEKIN Y, BUTUNER C: The effects of long-term oral administration of L-arginine on the erectile response of rabbits with alloxan-induced diabetes. BJU Int. (1999) 83:679–685.
   PubMedGoogle Scholar
• SULLIVAN ME, BELL CR, DASHWOOD MR et al.: Autoradiographic localisation of nitric oxide synthase binding sites in normal and diabetic rat corpus cavernosum. Eur. Um]. (1996) 30(4):506–511.
   PubMedGoogle Scholar
• ARI G, VARDI Y, FINBERG JPM: Nitric oxide and penile erection in streptozotocin-diabetic rats. Clin. Sci. (1999) 96:365–371.
   Google Scholar
• KHAN MA, THOMPSON CS, JEREMY JY, MUMTAZ FH, MIKHAILIDIS P, MORGAN RJ: The effect of superoxide dismutase on nitric oxide-mediated and electrical field stimulated diabetic rabbit cavernosal smooth muscle relaxation. BJU Int. (2000) 87:98–103.
   Google Scholar
• •• Key paper showing role of superoxide in mediating cavernosal dysfunction in alloxan-induced diabetic rabbits.
   Google Scholar
• LANGENSTROER P, PIPER GM: Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Arn. J. Phys. (1992) 63:H257–H265.
   Google Scholar
• KOTAKE M, SHINOHARA R, KATO K: Reduction of activity, but no decrease in concentration of erythrocyte Cu/Zn superoxide dismutase by hyperglycaemia in diabetic patients. Diabet. Merl (1998) 15:668–671.
   PubMed Web of Science ®Google Scholar
• VIJAYALINGHAM S et al: Abnormal anti-oxidant status in impaired glucose tolerance and non-insulin dependent diabetes mellitus. Diabet. Med. (1996) 13:715–719.
   PubMedGoogle Scholar
• KAMATA K, KOBAYASHI T: Changes insuperoxide dismutase mRNA expression by streptozotocin-induced diabetes. Br. J. Pharmacy]. (1996) 119:583–589.
   PubMed Web of Science ®Google Scholar
• BUCALA R, TRACEY K, CERAMI A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J. Gin. Invest. (1991) 87:432–438.
   PubMed Web of Science ®Google Scholar
• MULLARKEY CJ, EDELSTEIN D, BROWNLEE M: Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. (1990) 173:932–939.
   PubMed Web of Science ®Google Scholar
• HOFFMAN D et al.: Advanced glycationend-products quench cavernosal nitric oxide. I Ural. (1995) 153(Suppl.):441A.
   Google Scholar
• GANZ MB, SEFTEL A: Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am. I Physiel Endocrine]. Metab. (2000) 278(1):E146–E152.
   Google Scholar
• WAY WJ, KATAI N, KING GL: Protein kinase C and the development of diabetic vascular complications. Diabet. Med. (2001) 18(12):945–959.
   PubMedGoogle Scholar
• ZANETTI M et al.: Gene transfer of superoxide dismutase isoforms reverses endothelial dysfunction in diabetic rabbit aorta. Arm J. Physiel (2000) 280(6):H2516–H2523.
   Google Scholar
• CHRIST GJ, A MELMAN: The application of gene therapy to the treatment of erectile dysfunction. Int. I Impot. Res. (1998) 10:111–112.
   PubMedGoogle Scholar
• HALLIWELL B: The antioxidant paradox. Lancet (2000) 355:179–180.
   Google Scholar
• CZERNICHOW S, HERCBERG S: Interventional studies concerning the role of antioxidant vitamins in cardiovascular diseases: a review. J. Num. Health Aging (2001) 5(3):188–195.
   PubMedGoogle Scholar
• MARTINEZ C, SIMONSEN U: Decreased erectile function in renal hypertensive rats is improved with L-arginine treatment. hat. Impot. Res. (2001) 13\(Suppl. 4):525.
   Google Scholar
• CHEN J, WOLLMAN Y, CHERNICHOVSKY T, IAINA A, SOFER M, MATZKIN H: Effect of oral administration of high dose nitric oxide donor L-arginine in men with organic erectile dysfunction: results of a double blind, randomised, placebo-controlled study. BID Int. (1999) 83:269–273.
   Google Scholar
• KEEGAN A, COTTER MA, CAMERON NE: Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia (1999) 42:343–350.
   PubMed Web of Science ®Google Scholar
• ••Study showing near total prevention ofcavernosal dysfunction in diabetic rats through in vivo administration of a radical scavenger.
   Google Scholar
• KEEGAN A, COTTER MA, CAMERON NE: Corpus cavernosum dysfunction in diabetic rats: effects of combined alpha-lipoic acid and gamma-linoleic acid treatment. Diabetes Metab. Res. Rev (2001) 17:380–386.
   PubMedGoogle Scholar
• KEEGAN A, COTTER MA, CAMERON NE: Effects of chelator treatment on aorta and corpus cavernosum from diabetic rats. Free Rad. Biel Med (1999) 27(5/6):536–543.
   Google Scholar
• GOCMEN C, SECILMIS A, KUMCU EKet al.: Effects of vitamin E and sodiumselenate on neurogenic and endothelial relaxation of corpus cavernosum in the diabetic mouse. Ear: I Pharmacel (2000) 398:93–98.
   Google Scholar
• ••Study showing partially restorative effectsof sodium selenate and vitamin E on cavernosal dysfunction in diabetic mice
   Google Scholar
• MORELAND RB: Pathophysiology of erectile dysfunction: the contributions of trabecular structure to function and the role of functional antagonism. hat. Impel-. Res. (2000) 12 (Suppl. 4):539–546. ao. MERSDORF A, GOLDSMITH PC, DIEDERICHS W et al.: Ultrastructural changes in impotent penile tissue; a comparison of 65 patients. Ural. (1991) 145:749.
   Google Scholar
• WESPES E, GOES PMD, SCHULMAN C: Vascular impotence: focal or diffuse penile disease. Urel. (1992) 148:1435–1436.
   PubMedGoogle Scholar
• NEHRA A, AZADZOI K, MORELAND R: Cavernosal expandability is an erectile tissue mechanical property which predicts trabecular histology in an animal model of vasculogenic erectile dysfunction. Urel. (1998) 159:2229–2236.
   PubMed Web of Science ®Google Scholar
• HALLIWELL B: Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet (1994) 344:721–724.
   Google Scholar
• Second International Conference on Management of Erectile Dysfunction: consensus statement. Int. J Impel-. Res. (2002) 14 (Suppl.):S1–S5.
   Google Scholar
• ANDERSSON KE: Penile erectile function: recommendations for future research. hat. Impel-. Res. (2000) 12 (Suppl. 4):5163–5167. Affiliation RWA Jones BMedSci BM BS FRCS(Ed)L2, RW Rees BSc MB BS MRCS3, S Minhas MD3, D Ralph MD3, RA Persad ChM FRCS(UroO FEBUl & JY Jeremy MSc PhD2
   Google Scholar
• Bristol Royal Infirmary, Marlborough Street, Bristol B52 8HW, UK
   Google Scholar
• Bristol Heart Institute, Marlborough Street, Bristol B52 8HW, UK
   Google Scholar
• Institute of Urology and Nephrology, 48 Riding House Street, London, W1W 7EY, UK
   Google Scholar